2015
DOI: 10.1089/dna.2014.2590
|View full text |Cite
|
Sign up to set email alerts
|

Increased Levels of β-catenin, LEF-1, and HPA-1 Correlate with Poor Prognosis for Acral Melanoma with Negative BRAF and NRAS Mutation in BRAF Exons 11 and 15 and NRAS Exons 1 and 2

Abstract: To determine the expression of b-catenin, lymphoid enhancer-binding protein-1 (LEF-1), and heparanase-1 (HPA-1) and to evaluate these proteins' potential prognostic values in malignant acral melanoma without mutations in BRAF exons 11 and 15 and NRAS exons 1 and 2, specimens from 90 patients with wild-type BRAF and NRAS were assessed and analyzed by immunohistochemistry and western blotting. The positive expression of b-catenin, lymphoid enhancer-binding protein-1, and heparanase-1 was observed in 36 (72%), 31… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
15
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 22 publications
(15 citation statements)
references
References 38 publications
0
15
0
Order By: Relevance
“…It is confirmed that LEF1-positive tumours more frequently harboured KRAS mutations compared with LEF1-negative tumours in colorectal carcinomas, and patients with colorectal carcinoma with moderate or strong LEF1 expression tended to have worse overall survival compared with those with weak or negative LEF1 expression 6. Moreover, Xu et al assessed specimens from 90 patients with wild-type BRAF and NRAS, and they found that the expression of LEF1 was significantly positively correlated with the TNM stage as well as poor prognosis 16. It was also reported that LEF1 was more frequently expressed in moderately to poorly differentiated oral squamous cell cancer, and it might predict lymphovascular invasion and poor prognosis 17.…”
Section: Discussionmentioning
confidence: 96%
“…It is confirmed that LEF1-positive tumours more frequently harboured KRAS mutations compared with LEF1-negative tumours in colorectal carcinomas, and patients with colorectal carcinoma with moderate or strong LEF1 expression tended to have worse overall survival compared with those with weak or negative LEF1 expression 6. Moreover, Xu et al assessed specimens from 90 patients with wild-type BRAF and NRAS, and they found that the expression of LEF1 was significantly positively correlated with the TNM stage as well as poor prognosis 16. It was also reported that LEF1 was more frequently expressed in moderately to poorly differentiated oral squamous cell cancer, and it might predict lymphovascular invasion and poor prognosis 17.…”
Section: Discussionmentioning
confidence: 96%
“…Its overexpression in colon carcinoma cell lines could promote EMT by nuclear β-catenin activation (23). In general, these factors are usually associated with poor prognosis in different types of cancer (24)(25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35).…”
Section: Emt In Cancermentioning
confidence: 99%
“…15 In recent years, new possibly prognostic genetic biomarkers in ALM have been reported. High expression of b-catenin, lymphoid enhancer-binding protein-1 and heparanase-1 may be associated with poor prognosis and metastases in ALM, 39 and the TERT gene amplification was reported to be associated with overall survival and prognostic clinicopathological features in ALM. 40 In conclusion, ALM is a rare and distinctive subtype of CM, which has yet-to-be-defined mechanisms of pathogenesis.…”
Section: Year Of Diagnosismentioning
confidence: 99%